MedWire News - Diabetes - Pramlintide modestly lowers HbA1c, weight in Type 2 diabetes patients
Links shared publicly online about this topic.
- 701total visits
MedWire News - Diabetes - Pramlintide modestly lowers HbA1c, weight in Type 2 diabetes patients
MedWire News Results from a systematic review and meta-analysis show that pramlintide, a synthetic amylin analog, is modestly effective for reducing glycated hemoglobin and weight in Type 2 diabetic or obese patients. MedWire News
View full resource at medwire-news.md
Tags: Diabetes, Type 2 Diabetes, Obesity, News
Most Recently Shared on November 26, 2010 at 8:41 am By:
Pramlintide modestly lowers HbA1c, weight in Type 2 diabetes patients: Results from a systematic review and meta... http://bit.ly/fm84rs
Also Shared By:
Advertisement
Obesity OW
@Obesity_OW
Pramlintide modestly lowers HbA1c, weight in Type 2 diabetes patients: Results from a systematic review and meta... http://bit.ly/fm84rs
1 year ago...